A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108

[2] Bray F(1989)Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cancer 64 2448-2458

[3] Ferlay J(1992)A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 10 1066-1073

[4] Pisani P(2000)Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 3068-3077

[5] Sternberg CN(2005)Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 4602-4608

[6] Yagoda A(1989)Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of theurinary bladder Br J Urol 64 604-607

[7] Scher HI(1993)Carboplatin-based chemotherapy for bladder cancer Cancer Treat Rev 19 21-25

[8] Watson RC(1992)Carboplatin. methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy Cancer 70 1974-1979

[9] Geller N(2006)Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium Ann Oncol 17 113-117

[10] Herr HW(1995)Interaction between cisplatin and gemcitabine in vitro and in vivo Semin Oncol 22 72-79

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108

[2] Bray F(1989)Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cancer 64 2448-2458

[3] Ferlay J(1992)A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 10 1066-1073

[4] Pisani P(2000)Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 3068-3077

[5] Sternberg CN(2005)Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 4602-4608

[6] Yagoda A(1989)Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of theurinary bladder Br J Urol 64 604-607

[7] Scher HI(1993)Carboplatin-based chemotherapy for bladder cancer Cancer Treat Rev 19 21-25

[8] Watson RC(1992)Carboplatin. methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy Cancer 70 1974-1979

[9] Geller N(2006)Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium Ann Oncol 17 113-117

[10] Herr HW(1995)Interaction between cisplatin and gemcitabine in vitro and in vivo Semin Oncol 22 72-79